Literature DB >> 30868101

Action Myoclonus and Seizure in Kufor-Rakeb Syndrome.

Mohammad Rohani1,2, Anthony E Lang1,3, Farzad Sina1, Elahe Elahi4, Alfonso Fasano1,3, John Hardy5, Jose Bras5, Afagh Alavi6.   

Abstract

BACKGROUND: Kufor-Rakeb syndrome (KRS) is a rare autosomal recessive neurologic disease with diverse phenotypic features. Herein we report an Iranian KRS family with seizure and action myoclonus in addition to other typical manifestations of this syndrome.
METHOD: All family members underwent careful neurologic examination. Exome sequencing was performed and ATP13A2 variation genotyped in all family members.
RESULTS: Cognitive deficits, hypokinesia, rigidity, spasticity, brisk deep tendon reflexes, upward gaze palsy, tremor, and facial-faucial-finger mini-myoclonus were the common manifestations of all affected siblings. Two cases had seizure and the most severely affected sibling demonstrated severe action myoclonus. Exome sequencing identified a homozygous nonsense mutation c.2455C>T;p.Arg819* in ATP13A2 gene.
CONCLUSIONS: We reported five KRS affected siblings who manifested myoclonus and seizure. The most severely affected one demonstrated action myoclonus, which has not been reported so far.

Entities:  

Keywords:  ATP13A2 mutation; Kufor‐Rakeb syndrome; action myoclonus; neurodegeneration with brain iron accumulation; seizure

Year:  2017        PMID: 30868101      PMCID: PMC6407049          DOI: 10.1002/mdc3.12570

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  10 in total

1.  Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation.

Authors:  David Crosiers; Berten Ceulemans; Bram Meeus; Karen Nuytemans; Philippe Pals; Christine Van Broeckhoven; Patrick Cras; Jessie Theuns
Journal:  Parkinsonism Relat Disord       Date:  2010-11-20       Impact factor: 4.891

2.  Hereditary juvenile parkinsonism with pyramidal signs and mental retardation.

Authors:  N P Quinn; P J Goadsby; A J Lees
Journal:  Eur J Neurol       Date:  1995-03       Impact factor: 6.089

Review 3.  Parkinsonian-Pyramidal syndromes: A systematic review.

Authors:  Christine Tranchant; Meriam Koob; Mathieu Anheim
Journal:  Parkinsonism Relat Disord       Date:  2017-02-22       Impact factor: 4.891

4.  Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.

Authors:  Maria I Behrens; Norbert Brüggemann; Pedro Chana; Pablo Venegas; Marianne Kägi; Teresa Parrao; Patricia Orellana; Cristian Garrido; Cecilia V Rojas; Jan Hauke; Eric Hahnen; Rafael González; Nicolas Seleme; Verónica Fernández; Alexander Schmidt; Ferdinand Binkofski; Detlef Kömpf; Christian Kubisch; Johann Hagenah; Christine Klein; Alfredo Ramirez
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.

Authors:  David R Williams; Ali Hadeed; Amir S Najim al-Din; Abdel-Latif Wreikat; Andrew J Lees
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

7.  Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.

Authors:  A S Najim al-Din; A Wriekat; A Mubaidin; M Dasouki; M Hiari
Journal:  Acta Neurol Scand       Date:  1994-05       Impact factor: 3.209

8.  ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Authors:  Susanne A Schneider; Coro Paisan-Ruiz; Niall P Quinn; Andrew J Lees; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Mov Disord       Date:  2010-06-15       Impact factor: 10.338

9.  Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.

Authors:  Maryam Malakouti-Nejad; Gholam-Ali Shahidi; Mohammad Rohani; Seyed Mehdi Shojaee; Mehrdad Hashemi; Brandy Klotzle; Jian-Bing Fan; Elahe Elahi
Journal:  Neurosci Lett       Date:  2014-06-17       Impact factor: 3.046

10.  Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.

Authors:  Jose Bras; Alain Verloes; Susanne A Schneider; Sara E Mole; Rita J Guerreiro
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

  10 in total
  4 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Ataxia and Action Myoclonus Related to Novel Mutations in ATP13A2 Gene.

Authors:  Leire Manrique; Antonio Sánchez-Rodríguez; Ana L Pelayo-Negro; Marc Corral-Juan; Antoni Matilla-Dueñas; Jon Infante
Journal:  Mov Disord Clin Pract       Date:  2021-06-14

3.  Juvenile Parkinson Disease.

Authors:  Arsalan Anwar; Sidra Saleem; Aisha Akhtar; Sara Ashraf; Mirza Fawad Ahmed
Journal:  Cureus       Date:  2019-08-17

Review 4.  Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities.

Authors:  Iñigo Ruiz-Barrio; Andrea Horta-Barba; Ignacio Illán-Gala; Jaime Kulisevsky; Javier Pagonabarraga
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.